In Group 3, Lipo-DOX–2 treatment also inhibited the HETEs (8-HETE and 12-HETE), EETs (5,6-EET, 8,9-EET, 11,12-EET, and 14,15-EET), and LTA4 levels compared with the tumor control (Figure 4b). Here, LTA4H is linked to neoplasm.